Examination Syllabus Stage 2
Perioperative Medicine and Health Promotion (POM)
2_POM_A: Delivers high quality, individualised perioperative care to ASA 1-4 patients for elective surgery and ASA 1-3 emergency patients, focusing on optimising patient experience and outcome
| 2_POM_A_1 | The Identification and assessment of pathology in or around the airway, including but not limited to: • History and examination • Anaesthetic chart review • Interpretation of investigations such as lateral C-spine X-ray, cross sectional imaging of the upper airway (MRI/CT), flow volume loops, nasendoscopy • Discussion with surgeons |
| 2_POM_A_2 |
The preoperative assessment of patients with particular reference to associated co-morbidities and complex planned surgery. Including those for cardiothoracic, neuro, general, airway and plastic procedures.
|
| 2_POM_A_3 | The effects of ethnicity and patient diversity on pre-operative assessment |
2_POM_B: Liaises appropriately with other healthcare professionals to optimise patient care
| 2_POM_B_1 | Balances the need for early surgery against the need for further investigation, prehabilitation and pre-optimisation |
| 2_POM_B_2 | Contributes to discharge planning |
2_POM_C: Explains the principles of shared decision making
| 2_POM_C_1 | Shared decision making in the context of planning peri-operative care |
| 2_POM_C_2 | How a multidisciplinary team approach improves patient recovery and outcomes |
2_POM_D: Makes appropriate plans to mitigate co-morbidities and their treatment in the perioperative period, with particular reference to less common cardiovascular, neurological, respiratory, endocrine, haematological and rheumatological diseases
| 2_POM_D_1 | Understanding of the principles of anaesthesia for patients with neurological disease including but not limited to: • Guillain-Barré • Myasthenia gravis • Myasthenic syndrome • Dystrophia myotonica • Muscular dystrophy • Paraplegia and long-term spinal cord damage |
| 2_POM_D_2 | The abnormalities found in the adult patient with congenital heart disease [including corrected or partially corrected], and the implications for anaesthesia in these patients |
| 2_POM_D_3 | The effects of chemotherapy/radiotherapy and the implications for anaesthesia |
| 2_POM_D_4 | The perioperative management of patients undergoing transplant surgery |
| 2_POM_D_5 | The perioperative management of patients with transplanted organs for non-transplant surgery |
| 2_POM_D_6 | Appropriate preoperative strategies for minimising the use of blood products |
| 2_POM_D_7 | Assessment of the patient with complex comorbidities taking account of their individual needs and requirements including those with cardiac, respiratory, and renal disease |
| 2_POM_D_8 |
Endocrine abnormalities of significance to anaesthesia – e.g., Cushing’s, Addison’s, diabetes mellitus, thyroid/pituitary disease, phaeochromocytoma and the stress response
|
2_POM_E: Appreciates how integrated care pathways influence patient outcomes
| 2_POM_E_1 | The principles of enhanced recovery programmes |
| 2_POM_E_2 | The strategies for prehabilitation and patient optimisation and the limits of such strategies |
2_POM_F: Describes the use and limitations of common risk-scoring systems
| 2_POM_F_1 | Peri-operative risk assessment in patients with cardiac/respiratory disease or other co-morbidities, using common scoring systems including but not exclusively Lees RCRI, SORT, PPOSSUM, ACS NSQIP etc |
| 2_POM_F_2 | The uses and limitations of common risk scoring systems |
2_POM_G: Recognises when advanced physiological testing is indicated, interpreting the data to help stratify risk
| 2_POM_G_1 | Assessment of cardiac function including; Coronary angiography, ECHO, CT, MRI, nuclear imaging, and cardiopulmonary exercise testing both formal (CPET) and informal (six-minute shuttle tests) |
| 2_POM_G_2 | Assessment of respiratory function: blood gases, pulmonary function tests and diffusion capacity |
| 2_POM_G_3 | The use of specialised imaging techniques (e.g., CT, MRI) in planning anaesthesia and surgery for head and neck surgery |
| 2_POM_G_4 | The principles of preoperative evaluation of patients at risk of post-operative morbidity, including risk stratification tools e.g., · Scoring systems · Measures of functional capacity (including cardiopulmonary exercise testing) · Echocardiography |
| 2_POM_G_5 | Responds appropriately to investigation results when planning perioperative care |
| 2_POM_G_6 | Sleep studies - principles |
| 2_POM_G_7 | Interpretation of biochemical data |
| 2_POM_G_8 | Interpretation of haematological data |
| 2_POM_G_9 | Measurement of coagulation of the blood and interpretation of data including use of point of care tests eg TEG/ROTEM |
2_POM_H: Applies basic sciences to perioperative care
| 2_POM_H_1 | The pathophysiological changes and organ dysfunction associated with cardiac disease, and implications in the perioperative period |
| 2_POM_H_2 | The causes, pathophysiology and management of obstructive sleep apnoea and the surgical procedures used to treat |
| 2_POM_H_3 | The anaesthetic complications related to disturbance of fluid balance, oedema, and dehydration |
| 2_POM_H_4 | The rationale for and principles of perioperative haemodynamic management and optimisation, including management of phaeochromocytoma. |
| 2_POM_H_5 | Recognises that a relatively large proportion of patients requiring ophthalmic surgery are elderly and understands their particular needs including, but not exclusively, the effects of physiological changes associated with ageing and altered pharmacological responses |
2_POM_I: Applies the principles of public health interventions such as smoking cessation, reducing obesity and alcohol intake
| 2_POM_I_1 | The effects of smoking, excessive alcohol/drugs, and obesity on health |
2_POM_J: Recognises the potential harms of health care interventions
| 2_POM_J_1 | Adverse effects of medications in the peri-operative period eg antihypertensives, anticoagulants, hypoglycaemic agents, and anti-platelet medications |
2_POM_K: Explains how religious, cultural, and lifestyle factors may influence healthcare choices, such as blood transfusions, implants, and use of animal derived products
| 2_POM_K_1 | The particular sensitivity of patient choice even when this is not in line with accepted evidence based best practice e.g., choice of birth plan, and refusal of blood products |
| 2_POM_K_2 | How ethnicity and patient diversity may influence conduct of anaesthesia |
| 2_POM_L | Describes the needs and roles of carers and those providing support in the perioperative period and applies this to practice |
| 2_POM_M | Describes the requirement for postoperative organ support and its limitations |
| 2_POM_N | Applies end of life care as part of a multidisciplinary team |
2_POM_O: Explains and acts on the importance of perioperative management of haematological conditions including anaemia and coagulopathy
| 2_POM_O_1 | Management of concurrent use of anticoagulant/antiplatelet therapy |
| 2_POM_O_2 | Management of peri-operative anaemia |
2_POM_P: Recognises the factors associated with abnormal perioperative nutritional states and applies strategies to mitigate risks where appropriate
|
2_POM_P_1
|
Nutritional assessment techniques including laboratory tests |
| 2_POM_P_2 | Clinical consequences of poor nutritional status: including wound healing, infection, cardiovascular stability, thermoregulation, respiratory control |
2_POM_Q: Applies adjustments required that co-existing disease and surgical complexity have on the conduct of anaesthesia and perioperative care, including frailty, cognitive impairment and the impact of substance abuse or obesity
| 2_POM_Q_1 | Perioperative implications of bariatric surgery |
| 2_POM_Q_2 | Recognition and management of patient with frailty including use of clinical frailty scoring system |
| 2_POM_R | Demonstrates adjustments in perioperative care for children with co-morbidity |
| 2_POM_S | Plans appropriate obstetric anaesthetic care for all parturients collaboratively with the wider multi-disciplinary team |
2_POM_T: Recognises and manages critical illness in patients, including immediate resuscitation, and leads the care of acute obstetric emergencies
| 2_POM_T_1 | Recognition and management of amniotic fluid embolus |